No profile data available.
Processa Pharmaceuticals, Inc. (PCSA) is a healthcare company in the additional cancer treatment drugs industry, based in Vero Beach, United States, with about 12 full-time employees.
It reported revenue of $0 for fiscal year 2024, and net income of -$11.85 million. In Q2 2025 (the quarter ended June 30, 2025) revenue was $0. Its market capitalization was $4.25 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2024; market data as of October 9, 2026.
, a clinical-stage biopharmaceutical company, develops cancer therapy drugs to improve the safety and efficacy of cancer treatment in the United States.
Processa Pharmaceuticals reported $0 in revenue for fiscal year 2024. In Q2 2025 revenue was $0.
$4.25 million as of October 9, 2026.
Listed companies of a similar size in the same industry (additional cancer treatment drugs) include Liminatus Pharma, Inc. (LIMN), NuCana plc (NCNA), PharmaCyte Biotech, Inc. (PMCB), Calidi Biotherapeutics, Inc. (CLDI).